CST4 and asthma: This study aimed to assess the potential of recombinant T. spiralis novel cystatin (rTsCstN) in suppressing OVA-specific Th2 responses in an asthma mouse model based on the immunomodulatory properties exhibited by helminth cystatins in reducing airway inflammation.